Literature DB >> 17572399

Synthesis of CMP-9''-modified-sialic acids as donor substrate analogues for mammalian and bacterial sialyltransferases.

Yasuhiro Kajihara1, Toshimi Kamitani, Reiko Sato, Naoki Kamei, Tatsuo Miyazaki, Ryo Okamoto, Thoru Sakakibara, Takashi Tsuji, Takeshi Yamamoto.   

Abstract

Cytidine-5'-monophospho-sialic acid (CMP-Neu5Ac) derivatives bearing a phenyl group in which the tether length between the phenyl group and the 9-position of Neu5Ac varied were synthesized and evaluated as substrates for sialyltransferases. In the synthesis of the compounds, a coupling reaction between methyl 5-acetamido-4,7,8-tri-O-acetyl-9-azido-3,5,9-trideoxy-beta-D-glycero-D-galacto-2-nonulopyranosonate and 2-cyanoethyl 2',3'-O,N4, triacetylcytidine-5'-yl N,N-diisopropylphosphoramidite was carried out and the phosphite derivative thus obtained was oxidized and then deprotected to yield CMP-9''-azido-Neu5Ac. Modification of the 9-amino group prepared by reduction of the azido groups was performed by the use of several phenyl-substituted alkylcarboxylic acid derivatives. Using these CMP-9''-modified-Neu5Ac analogues bearing the phenyl-substituted alkyl-amide group, sialyltransferase assays were performed with both rat liver alpha-(2-->6)-sialyltransferase and Photobacterium alpha-(2-->6)-sialyltransferase. These 9-modified analogues could be transferred to disaccharide acceptors, and a practical enzymatic synthesis using CMP-9''-modified-Neu5Ac yielded sialoside analogues and sialylglycoproteins in good yield. These experiments demonstrate that the Photobacterium sialyltransferase can be used in the synthesis of sialoside analogues having a large substituent at the 9-position of Neu5Ac.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17572399     DOI: 10.1016/j.carres.2007.05.029

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  4 in total

1.  Selective exo-enzymatic labeling of N-glycans on the surface of living cells by recombinant ST6Gal I.

Authors:  Ngalle Eric Mbua; Xiuru Li; Heather R Flanagan-Steet; Lu Meng; Kazuhiro Aoki; Kelley W Moremen; Margreet A Wolfert; Richard Steet; Geert-Jan Boons
Journal:  Angew Chem Int Ed Engl       Date:  2013-10-15       Impact factor: 15.336

2.  Preparation of well-defined antibody-drug conjugates through glycan remodeling and strain-promoted azide-alkyne cycloadditions.

Authors:  Xiuru Li; Tao Fang; Geert-Jan Boons
Journal:  Angew Chem Int Ed Engl       Date:  2014-05-23       Impact factor: 15.336

3.  One-Step Selective Exoenzymatic Labeling (SEEL) Strategy for the Biotinylation and Identification of Glycoproteins of Living Cells.

Authors:  Tiantian Sun; Seok-Ho Yu; Peng Zhao; Lu Meng; Kelley W Moremen; Lance Wells; Richard Steet; Geert-Jan Boons
Journal:  J Am Chem Soc       Date:  2016-09-01       Impact factor: 15.419

Review 4.  Aberrant Sialylation in Cancer: Biomarker and Potential Target for Therapeutic Intervention?

Authors:  Silvia Pietrobono; Barbara Stecca
Journal:  Cancers (Basel)       Date:  2021-04-22       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.